![Kaye Foster-Cheek](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Kaye Foster-Cheek
Director/Board Member at
PRIME MEDICINE, INC.
Net worth: 284 239 $ as of 31/05/2026
Profile
Kaye I.
Foster-Cheek is currently Chairman at Glide Memorial United Methodist Church, Lead Independent Director at Agios Pharmaceuticals, Inc. since 2023, Director at Stanford Health Care-Stanford Hospital, Girls for a Change, Xaira Therapeutics, Inc., National Resilience, Inc., and a Trustee at Spelman College and ValleyCare Health System.
Kaye is also an Independent Director at Prime Medicine, Inc. since 2021 and a Venture Partner at ARCH Venture Partners LLC since 2022.
Former roles include Director at Resilience, Inc. and GRAIL, Inc., Vice President-Human Resources at Johnson & Johnson from 2003 to 2010, Senior Vice President-Global Human Resources at Onyx Pharmaceuticals, Inc. from 2010 to 2014, Senior Advisor at The Boston Consulting Group, Inc., and Trustee at Glide Foundation.
Education includes an undergraduate degree from Baruch College, conferred in 1988.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 31/03/2026 | 9,668 ( 0.02% ) | 284 239 $ | 31/05/2026 | |
PRIME MEDICINE, INC. -.--% | 05/06/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
Kaye Foster-Cheek active positions
| Companies | Position | Start |
|---|---|---|
| AGIOS PHARMACEUTICALS, INC. | Director/Board Member | 09/12/2014 |
| PRIME MEDICINE, INC. | Director/Board Member | 01/12/2021 |
ValleyCare Health System
 ValleyCare Health System Hospital/Nursing ManagementHealth Services Provides healthcare services | Director/Board Member | - |
ARCH Venture Partners LLC
 ARCH Venture Partners LLC Investment ManagersFinance ARCH Venture Partners invests in disruptive science companies located in the United States. The firm target companies operating in the fields of biotechnology and technology sectors. It provides financing for early stage capital requirements with a minimum investment size of $0.05 million and also makes co-investments. | Private Equity Investor | 12/01/2022 |
National Resilience, Inc.
 National Resilience, Inc. BiotechnologyHealth Technology Operates as a biomanufacturing company that develops and produces medicines | Director/Board Member | - |
Glide Memorial United Methodist Church | Chairman | - |
Girls for a Change | Director/Board Member | - |
Spelman College
 Spelman College Other Consumer ServicesConsumer Services Functions as a College/University | Director/Board Member | - |
Stanford Health Care
 Stanford Health Care Hospital/Nursing ManagementHealth Services Operates as healthcare center | Director/Board Member | - |
Former positions of Kaye Foster-Cheek
| Companies | Position | End |
|---|---|---|
| ░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░ ░░░░░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | - |
| ░░░░░ ░░░░░░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
| ░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
| ░░░ ░░░░░░ ░░░░░░░░░░ ░░░░░░ ░░░░ | ░░░░░░░░░░ ░ ░░░░░░░ | - |
Training of Kaye Foster-Cheek
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
73
1st degree connections
17
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 17 |
|---|---|
Johnson & Johnson
 Johnson & Johnson Pharmaceuticals: MajorHealth Technology Operates as an investment holding company with interests in health care products | Health Technology |
Onyx Pharmaceuticals, Inc.
 Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that provide therapeutics for cancer | Health Technology |
ARCH Venture Partners LLC
ARCH Venture Partners LLC Investment ManagersFinance ARCH Venture Partners invests in disruptive science companies located in the United States. The firm target companies operating in the fields of biotechnology and technology sectors. It provides financing for early stage capital requirements with a minimum investment size of $0.05 million and also makes co-investments. | Finance |
Glide Foundation
 Glide Foundation Miscellaneous Commercial ServicesCommercial Services Provides social services | Commercial Services |
Agios Pharmaceuticals, Inc.
 Agios Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops therapeutics | Health Technology |
The Boston Consulting Group, Inc.
 The Boston Consulting Group, Inc. Miscellaneous Commercial ServicesCommercial Services Provides management consulting services | Commercial Services |
Spelman College
Spelman College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Baruch College
 Baruch College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
ValleyCare Health System
ValleyCare Health System Hospital/Nursing ManagementHealth Services Provides healthcare services | Health Services |
Stanford Health Care
Stanford Health Care Hospital/Nursing ManagementHealth Services Operates as healthcare center | Health Services |
Resilience, Inc.
 Resilience, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as non-profit organization for hands-on workshop covering free-range poultry production, processing and marketing | Commercial Services |
Columbia Business School
 Columbia Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Girls for a Change | |
GRAIL, Inc.
 GRAIL, Inc. Medical SpecialtiesHealth Technology Manufactures cancer detection test kits and provides related services | Health Technology |
Glide Memorial United Methodist Church | |
Prime Medicine, Inc.
 Prime Medicine, Inc. BiotechnologyHealth Technology Develops CRISPR gene editing technology | Health Technology |
National Resilience, Inc.
National Resilience, Inc. BiotechnologyHealth Technology Operates as a biomanufacturing company that develops and produces medicines | Health Technology |
- Stock Market
- Insiders
- Kaye Foster-Cheek
